Voyager Acquisition Corp./Cayman Islands
VACH$270M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaHOUSTON
Drugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
May 2027
Market Overview
Stock performance and key metrics
VACH News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
VP4896
Alzheimer's Disease
Leuprolide acetate
Alzheimer Disease
VY7523
Alzheimer's Disease (AD)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VP4896 | Phase 3 | Alzheimer's Disease | - | - |
Leuprolide acetate | Phase 2 | Alzheimer Disease | - | - |
VY7523 | Phase 2 | Alzheimer's Disease (AD) | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply